Published in Carcinogenesis on March 01, 2002
Current mouse and cell models in prostate cancer research. Endocr Relat Cancer (2013) 0.92
Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old. Mol Cancer (2010) 0.87
Genetic background influences murine prostate gene expression: implications for cancer phenotypes. Genome Biol (2007) 0.86
Telomerase immortalization of principal cells from mouse collecting duct. Am J Physiol Renal Physiol (2010) 0.82
Glutathione S-transferase Pi mediates proliferation of androgen-independent prostate cancer cells. Carcinogenesis (2008) 0.81
Development of animal models underlining mechanistic connections between prostate inflammation and cancer. World J Clin Oncol (2013) 0.79
Characterization of SV-40 Tag rats as a model to study prostate cancer. BMC Cancer (2009) 0.77
Prostate carcinoma in transgenic Lewis rats - a tumor model for evaluation of immunological treatments. Chin Clin Oncol (2013) 0.76
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell (2005) 2.65
Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2003) 1.23
Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Gastroenterology (2003) 1.19
Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. Prostate (2009) 1.08
Increased intake of n-3 polyunsaturated fatty acids elevates the level of apoptosis in the normal sigmoid colon of patients polypectomized for adenomas/tumors. Cancer Lett (2003) 1.07
Gap junction dysfunction reduces acetaminophen hepatotoxicity with impact on apoptotic signaling and connexin 43 protein induction in rat. Toxicol Pathol (2010) 1.03
Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. Asian Pac J Cancer Prev (2008) 1.03
Maternal exposure to anti-androgenic compounds, vinclozolin, flutamide and procymidone, has no effects on spermatogenesis and DNA methylation in male rats of subsequent generations. Toxicol Appl Pharmacol (2009) 1.03
Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. Gastroenterology (2008) 1.02
Suppression of prostate cancer in a transgenic rat model via gamma-tocopherol activation of caspase signaling. Prostate (2009) 1.02
Prevention by natural food anthocyanins, purple sweet potato color and red cabbage color, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in rats initiated with 1,2-dimethylhydrazine. J Toxicol Sci (2002) 1.01
Specific differences in gene expression profile revealed by cDNA microarray analysis of glutathione S-transferase placental form (GST-P) immunohistochemically positive rat liver foci and surrounding tissue. Carcinogenesis (2003) 1.00
Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo. EMBO J (2010) 1.00
Malignant solitary fibrous tumor of the meninges. Virchows Arch (2004) 1.00
Effect of heat therapy using magnetic nanoparticles conjugated with cationic liposomes on prostate tumor in bone. Prostate (2008) 1.00
Tbx3 expression is related to apoptosis and cell proliferation in rat bladder both hyperplastic epithelial cells and carcinoma cells. Cancer Lett (2005) 1.00
Differences in gene expression profiles in the liver between carcinogenic and non-carcinogenic isomers of compounds given to rats in a 28-day repeat-dose toxicity study. Toxicol Appl Pharmacol (2006) 0.99
Expression of prothymosin alpha is correlated with development and progression in human prostate cancers. Prostate (2006) 0.98
TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2. Proc Natl Acad Sci U S A (2011) 0.98
Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers. Prostate (2003) 0.97
Silencing of connexin 43 suppresses invasion, migration and lung metastasis of rat hepatocellular carcinoma cells. Cancer Sci (2012) 0.96
Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune-response induction in transplanted syngeneic rats. Prostate (2005) 0.96
A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci (2003) 0.95
Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation. Cancer Sci (2008) 0.95
Rapid analysis of gene expression changes caused by liver carcinogens and chemopreventive agents using a newly developed three-dimensional microarray system. Cancer Sci (2004) 0.94
Complete regression of experimental prostate cancer in nude mice by repeated hyperthermia using magnetite cationic liposomes and a newly developed solenoid containing a ferrite core. Prostate (2006) 0.93
Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment. Cancer Sci (2008) 0.92
Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo. Cancer Sci (2010) 0.91
High susceptibility of the ACI and spontaneously hypertensive rat (SHR) strains to 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) prostate carcinogenesis. Cancer Sci (2003) 0.91
Early dynamics of hepatitis B virus in chimeric mice carrying human hepatocytes monoinfected or coinfected with genotype G. Hepatology (2007) 0.91
Linkage and microarray analyses of susceptibility genes in ACI/Seg rats: a model for prostate cancers in the aged. Cancer Res (2005) 0.91
Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens. Cancer Res (2007) 0.90
Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells. Cancer Sci (2007) 0.90
Suppression of metastasis by nuclear factor kappaB inhibitors in an in vivo lung metastasis model of chemically induced hepatocellular carcinoma. Cancer Sci (2004) 0.90
Apocynin, an NADPH oxidase inhibitor, suppresses rat prostate carcinogenesis. Cancer Sci (2013) 0.89
Connexin 32 dominant-negative mutant transgenic rats are resistant to hepatic damage by chemicals. Hepatology (2004) 0.88
Low-fat milk promotes the development of 7,12-dimethylbenz(A)anthracene (DMBA)-induced mammary tumors in rats. Int J Cancer (2004) 0.88
Lack of mutation induction with exposure to 1.5 GHz electromagnetic near fields used for cellular phones in brains of Big Blue mice. Cancer Res (2002) 0.88
Age-dependent histopathological findings in the prostate of probasin/SV40 T antigen transgenic rats: lack of influence of carcinogen or testosterone treatment. Cancer Sci (2003) 0.87
Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline or N-nitrosodiethylamine. Jpn J Cancer Res (2002) 0.87
Differences between latent and clinical prostate carcinomas: lower cell proliferation activity in latent cases. Prostate (2006) 0.87
Lack of adverse effects of whole-body exposure to a mobile telecommunication electromagnetic field on the rat fetus. Radiat Res (2010) 0.87
A medium-term, rapid rat bioassay model for the detection of carcinogenic potential of chemicals. Toxicol Pathol (2010) 0.86
DNA methylation in the androgen receptor gene promoter region in rat prostate cancers. Prostate (2002) 0.86
Characteristics of hepatitis B virus genotype G coinfected with genotype H in chimeric mice carrying human hepatocytes. Virology (2008) 0.86
Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis (2003) 0.85
Downregulation of apoptosis revealed by laser microdissection and cDNA microarray analysis of related genes in rat liver preneoplastic lesions. Med Mol Morphol (2005) 0.85
Effects on rat testis of 1.95-GHz W-CDMA for IMT-2000 cellular phones. Syst Biol Reprod Med (2011) 0.84
Disruption of growth hormone signaling retards prostate carcinogenesis in the Probasin/TAg rat. Endocrinology (2007) 0.84
Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3. Food Chem Toxicol (2012) 0.84
Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers. Cancer Res (2008) 0.84
Therapeutic targeting of angiotensin II receptor type 1 to regulate androgen receptor in prostate cancer. Prostate (2012) 0.84
Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment. Jpn J Cancer Res (2002) 0.84
Apocynin, an NADPH oxidase inhibitor, suppresses progression of prostate cancer via Rac1 dephosphorylation. Exp Toxicol Pathol (2013) 0.84
Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice. Cancer Sci (2003) 0.84
Undifferentiated Sarcoma of the Salivary Gland in a Mongolian Gerbil (Meriones unguiculatus). J Toxicol Pathol (2011) 0.84
Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf. Cancer Lett (2011) 0.84
Chemoprevention of heterocyclic amine-induced mammary carcinogenesis in rats. Environ Mol Mutagen (2002) 0.83
A 13-week repeated dose study of three 3-monochloropropane-1,2-diol fatty acid esters in F344 rats. Arch Toxicol (2014) 0.83
Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats. J Pharmacol Exp Ther (2004) 0.83
Effects of gestational exposure to 1.95-GHz W-CDMA signals for IMT-2000 cellular phones: Lack of embryotoxicity and teratogenicity in rats. Bioelectromagnetics (2009) 0.83
Elevated expression of coactivator-associated arginine methyltransferase 1 is associated with early hepatocarcinogenesis. Oncol Rep (2013) 0.83
Pitfalls with MRI evaluation of prostate cancer detection: comparison of findings with histopathological assessment of retropubic radical prostatectomy specimens. Urol Int (2006) 0.83
Reversibility of proliferative lesions and induction of non-papillary tumors in rat urinary bladder treated with phenylethyl isothiocyanate. Carcinogenesis (2003) 0.82
Purple corn color inhibition of prostate carcinogenesis by targeting cell growth pathways. Cancer Sci (2013) 0.82
Influence of atrazine administration and reduction of calorie intake on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats. Cancer Sci (2005) 0.82
Optimization of an animal test protocol for toxicogenomics studies (ii); a cross-laboratory gene expression analysis. J Toxicol Sci (2007) 0.82
Both early and late stages of hepatocarcinogenesis are enhanced in Cx32 dominant negative mutant transgenic rats with disrupted gap junctional intercellular communication. J Membr Biol (2007) 0.82
Involvement of toxicity as an early event in urinary bladder carcinogenesis induced by phenethyl isothiocyanate, benzyl isothiocyanate, and analogues in F344 rats. Toxicol Pathol (2003) 0.82
Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma. Jpn J Cancer Res (2002) 0.82
Optimization of an animal test protocol for toxicogenomics studies (I); requirement study of a protocol. J Toxicol Sci (2007) 0.82
Reactive angioendotheliomatosis of the intestine. Am J Surg Pathol (2004) 0.81
Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation. Int J Cancer (2008) 0.81
Down-regulation of human X-box binding protein 1 (hXBP-1) expression correlates with tumor progression in human prostate cancers. Prostate (2002) 0.81
Organ specific Gst-pi expression of the metastatic androgen independent prostate cancer cells in nude mice. Prostate (2011) 0.81
Ellagic acid, a component of pomegranate fruit juice, suppresses androgen-dependent prostate carcinogenesis via induction of apoptosis. Prostate (2014) 0.81
Possible enhancing activity of diacylglycerol on 4-nitroquinoline 1-oxide induced carcinogenesis of the tongue in human c-Ha-ras proto-oncogene transgenic rats. Food Chem Toxicol (2006) 0.81
Histone H1 expression in human prostate cancer tissues and cell lines. Pathol Int (2011) 0.81
Ellagic acid inhibits migration and invasion by prostate cancer cell lines. Asian Pac J Cancer Prev (2013) 0.81
Glutathione S-transferase Pi mediates proliferation of androgen-independent prostate cancer cells. Carcinogenesis (2008) 0.81
Local and systemic delivery of siRNAs for oligonucleotide therapy. Methods Mol Biol (2009) 0.80
A 90-day oral toxicity study of purple corn color, a natural food colorant, in F344 rats. Food Chem Toxicol (2007) 0.80
Discrimination of carcinogens by hepatic transcript profiling in rats following 28-day administration. Cancer Inform (2009) 0.80
Effects of nobiletin on PhIP-induced prostate and colon carcinogenesis in F344 rats. Nutr Cancer (2011) 0.80
Clinicopathological significance of BRCA1 promoter hypermethylation in Thai breast cancer patients. Asian Pac J Cancer Prev (2014) 0.80
Depression of T cell-mediated immunity reduces sulfadimethoxine-induced capsular inflammation and inhibits associated development of invasive thyroid follicular cell carcinomas in rats. Cancer Sci (2007) 0.79
Quantitative proteomic analysis of rat liver for carcinogenicity prediction in a 28-day repeated dose study. Proteomics (2007) 0.79